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Summary
Objectives: The purpose of the study was to determine the difference in time until the appearance of relapse or metas-
tases in patients treated for colorectal cancer, depending on the location of the tumor in the left or right colon at the oncol-
ogy clinic of clinical Medical centre osijek between 1st January 2010 and 31st December 2012.
Study design: historical prospective study
Material and methods: study included patients whose data were recorded from medical archive at the oncology clinic 
of Clinical Medical Centre Osijek. The data on patients’ deaths were recorded from the Registry Office of the Republic of 
croatia.
Results: the study included 272 patients, 160 (58.8%) men and 112 (41.2%) women. according to the location, left sided 
colon tumor was discovered in 211 (77.6%) patients and right-sided in 61 (22.4%). the median age was 67 years. right-sided 
colon tumors are considerably larger with median diameter of 6 cm, with median number of 16. Median of time until the ap-
pearance of the metastases is 20 months (interquartile range is from 8 to 29 months); marked time being shorter in right-sided 
colon tumors. Positive outcome of the treatment was achieved in 205 (75.4%) patients, with no significant difference in com-
parison to the colon cancer localization. By using Kaplan-Meier analysis of patients’ survival rates, a total 5- year survival rate 
of 72% was achieved in right-sided colon tumor in comparison to 62% in patients with the left-sided colon tumor.
Conclusion: This study confirms that there is a difference in colorectal cancer according to its localisation. Patients with 
right-sided colorectal cancer are older, the carcinoma is larger, the time until the appearance of a relapse or a metastases is 
shorter in right sided colon cancer while 5-year survival rate is lower in left sided colon cancer. 
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RAZLIKA IZMEĐU KARAKTERISTIKA BOLESNIKA S KARCINOMOM LIJEVOG I DESNOG KOLONA  
- ISKUSTVO JEDNE USTANOVE
Sažetak
Cilj Istraživanja: Utvrditi razliku u vremenu do pojave recidiva ili presadnica kod bolesnika liječenih zbog kolorektal-
nog karcinoma ovisno o smještaju u lijevom ili desnom kolonu u pacijenata liječenih na Zavodu za onkologiju, KBC-a Osijek 
od 1. siječnja 2010. do 31. prosinca 2012.
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Nacrt studije: povijesno prospektivna studija
Materijal i metode: U istraživanje su uključeni ispitanici čiji su podatci preuzeti iz arhive medicinske dokumentacije Zavo-
da za onkologiju KBC-a Osijek, podatci o smrti pacijenata preuzeti su od nadležnog Maticnog ureda Republike Hrvatske.
Rezultati: U istraživanje je uključeno 272 pacijenta, od kojih je 160 (58,8 %) muškaraca i 112 (41,2 %) žena. Prema loka-
lizaciji, ljevostrani tumor kolona ima 211 (77,6 %) bolesnika, a desnostrani njih 61 (22,4 %). središnja dob pacijenta (medijan) 
je 67 godina. Značajno su veći u promjeru desni tumori kolona, medijana 6 cm. Medijan vremena do pojave metastaza izno-
si 20 mjeseci (interkvartilnog raspona 8 do 29 mjeseci), pri čemu je značajnije kraći kod desnih tumora kolona. Pozitivan 
 ishod liječenja imalo je 205 (75,4 %) bolesnika, bez značajne razlike u odnosu na lokalizaciju tumora kolona. Kaplan – Meie-
rovom analizom preživljenja promatranih bolesnika podijeljenih prema lokalizaciji, dobiveno je petogodišnje ukupno pre-
življenje 72 % za tumor u desnom kolonu, u odnosu na 62 % kod bolesnika koji su imali tumor u lijevom kolonu.
Zaključak: U ovom istraživanju potvrđeno je da postoji razlika u kolorektalnom karcinomu s obzirom na njegov polo-
žaj. Pacijenti s desnim kolorektalnim karcinomom su starije dobi, tumor je veći u promjeru,vrijeme do pojave presadnica ili 
recidiva je kraće, te je petogodišnje preživljavanje manje.
Ključne rijeci: kolorektalni karcinom, onkologija, kolon
INTRODUCTION
colorectal cancer is the third most frequent 
malignant tumor in the world. the newer studies 
indicate that tumors behave differently, depend-
ing on their position – left or right. an historical - 
prospective study has been carried out in which 
various parameters were examined. these are the 
parameters of the carcinoma itself and its behav-
iour in the left or right colon, as well as the behav-
iour of left and right colon cancer according to dif-
ference in sex, tnM characteristics, time until the 
appearance of metastases or recidive, age limit 
and patients’ survival rate (1,2,6).
the colon was developed from the primitive 
gut. the development of the primitive gut and its 
derivatives is divided into four segments: esopha-
gus, foregut, midgut and hindgut. the colon has 
different development because it was developed 
from the mid and hindgut. after the development 
ended, the midgut starts distally from the entry of 
gallibladder into the duodendum and it ends at 
the boundary between proximal 2/3 and distal 1/3 
of the transverse colon, and through its whole 
lenght it is supplied by blood from a. mesenterica 
superior. from the hindgut develops distal 1/3 of 
the colon, descending colon, sigmoid colon, rec-
tum and the lower half of the anal canal (3).
the frequency of the carcinoma itself rises si-
multaneously with the industrial development of 
each country. the highest incidence rates are re-
corded in new Zealand, the Usa, canada and 
great Britain, while low rates are registered in af-
rican countries, asia and some parts of south 
america. in the republic of croatia the incidence 
and mortality rates are similar to the median val-
ues in developed countries. in 2012 the incidence 
rate of colorectal cancer was 44,2/100000 in men, 
and 24,7/100000 in women; the mortality rate in 
men was 26,7/100000, and in women 24,7/100000. 
colorectal cancer is among ten most common 
causes of death in osijek-Baranya county; it was 
ranked fourth with 158 deaths in 2016 (1,4,5,10,11).
the cause of colorectal carcinoma itself, as 
well as of many other malignant diseases, remains 
unknown. However, it is known that certain fac-
tors can have an enormous influence on its devel-
opment. risk factors such as old age, nutrition 
rich in fat, but poor in fibres, contributes to the ap-
pearance of colorectal cancer. genetic factors such 
as family adenomatose polyposis of the colon also 
add to its appearance (1,2).
Hereditary predispositions, inflammatory in-
testine diseases, especially ulcerative colitis, as 
well as patiens who have already had a colorectal 
carcinoma and have undergone surgery, have a 
greater risk of developing this carcinoma (1,2).
pathological-anatomically speaking, most 
commonly it is an adenocarcinoma, localized in 
rectum and sigmoid colon, around 73%, rarely in 
ascending colon, around 14%. and in trensverse 
colon, around 10%. according to gradus, we dis-
tinguish well differentiated, moderately differen-
tiated and poorly differentiated. For clinical pur-
poses the greatest influence has a pathohistologi-
cal classification, which was introduced in 1930 by 




study includes patients whose data were tak-
en from medical archive at the oncology clinic of 
clinical Medical centre osijek. the data on pa-
tients’ deaths were taken from the Registry Office 
of the republic of croatia. 272 patients were in-
volved from 2010 to 2012, including 2012
RESULTS
in the research 272 patients were involved 
from 2010 to 2012, including 2012, 160 (58,8 %) 
men and 112 (41,2 %) women. according to tumor 
localization, left colon cancer had 211 (77,6 %) pa-
tients, and right colon cancer 61 patients (22,4 %).
table 1 is showing clinical-pathological and de-
mographic data (table 1.). in the research colon 
transversum was used as the border between left 
and right colon.
nodes is not significantly different according to 
colon cancer localization (table 2.)
the highest number of patients, 214 (78,7 %), 
had t3 stage of the primary tumor, and in 157 
(57,7 %) patients, regional lymph nodes not invad-
ed. lymphovascular invasion was not present in 
221 (81,3 %) patients. There were no significant 
differences according to the colon cancer localiza-
tion in terms of regional or local invasion (table 3)
Table 1.
LOCALIZATION OF COLON CANCER ACCORDING TO 
PATIENTS’ GENDER AND AGE
Number (%) of patients according to 







Men 35 (57,4) 125 (59,2) 160 (58,8)
0,88
Women 26 (42,6) 86 (40,8) 112 (41,2)
Patients’ age
to 50 years 5 (8,2) 17 (8,1) 22 (8,1)
0,09
51 – 60 7 (11,5) 57 (27) 64 (23,5)
61 – 70 22 (36,1) 57 (27) 79 (29)
71 – 80 23 (37,7) 72 (34,1) 95 (34,9)
81 years  
and older 4 (6,6) 8 (3,8) 12 (4,4)
Total 61 (100) 211 (100) 272 (100)
*fisher’s exact test
Median age was 67 years (interquartil range 
from 58 – 74 years) at the range from 31 to 88 years. 
Most patients, 95 (34,9 %) were between 71 and 80 
years old. Right colon cancer is significantly larg-
er, median value 6 cm (interquartil range from 4,5 
to 7 cm) at the range from 2 cm to 13 cm (Mann – 
Whitney U test, p = 0, 008), as well as the number 
of examined lymph nodes, median value 16 (inter-
quartil range from 10 to 22) (Mann – Whitney U 
test, P < 0, 001). The number of infiltrated lymph 
Table 3.
T I N STAGE AND THE LYMPHOVASCULAR INVASION 
ACCORDING TO COLON CANCER LOCALIZATION








T1 1 (1,6) 2 (0,9) 3 (1,1)
0,88
T2 10 (16,4) 37 (17,5) 47 (17,3)
T3 49 (80,3) 165 (78,2) 214 (78,7)
T4 1 (1,6) 7 (3,3) 8 (2,9)




34 (55,7) 123 (58,3) 157 (57,7)
0,11†
N1 10 (16,4) 53 (25,1) 63 (23,2)
N2 17 (27,9) 35 (16,6) 52 (19,1)
Limphovascular invasion
Not present 52 (85,2) 169 (80,1) 221 (81,3)
0,46
Present 9 (14,8) 42 (19,9) 51 (18,8)
Total 61 (100) 211 (100) 272 (100)
*fisher’s exact test; †χ2 test
Table 2.
PATIENTS’ AGE, THE SIZE OF CANCER AND THE NUMBER 
OF EXAMINED AND INVOLVED LYMPH NODES
Median (interquartil range) according 














The tumor size 
(cm) 6 (4,5 – 7) 5 (4 – 6) 5 (4 – 6, 5) 0,008









The number of 
involved lymph 
nodes
0 (0 – 4) 0 (0 – 2) 0 (0 – 2) 0,31
*Mann – Whitney U test
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Metastases were found in 27 (9,9 %) of pa-
tients, and the most frequent localization of the 
metastases is in liver in 18/26 of patients (table 4). 
regarding the tumor stage, the highest num-
ber of patients, 114 (41,9%), had stage iia, and 70 
(25,7 %) has stage iiiB. according to the tumor 
grading system, 102 of tumor patients (37,5%) had 
grade i, 132 (48,5%) grade ii, and 38 (14%) grade 
III. There was no significant difference regarding 
colon cancer localization in terms of grade or stage 
(table 5). 
Most patients received adjuvant therapy was 
administered (189 patients; 69,5%). from the total 
number of 152 (80,4%) patients, who received che-
motherapy only, there are significantly more pa-
tients with right colon cancer, while those with left 
colon cancer received radiotherapy or chemoradio-
therapy (fisher’s exact test, p < 0,001) (table 6).
Table 4.
THE EXISTENCE AND LOCALIZATION OF METASTASES 
ACCORDING TO COLON CANCER LOCALIZATION
Number (%) of patients according to 







Yes 7 (11,5) 20 (9,5) 27 (9,9)
0,63
No 54 (88,5) 191 (90,5) 245 (90,1)
Total 61 (100) 211 (100) 272 (100)
Localization of metastases
Liver 5/7 13/19 18/26
0,92
Lungs 0 2/19 2/26
Peritoneus 0 1/19 1/26
Other 1/7 2/19 3/26
Liver and lungs 1/7 1/19 2/26
Total 7/7 19/19 26/26
*fisher’s exact test
Table 5.
TUMOR STAGE AND GRADUS ACCORDING TO THE COLON 
CANCER LOCALIZATION
Number (%) of patients according to 







I 6 (9,8) 31 (14,7) 37 (13,6)
0,65
IIA 28 (45,9) 86 (40,8) 114 (41,9)
IIB 0 3 (1,4) 3 (1,1)
IIC 0 1 (0,5) 1 (0,4)
IIIA 2 (3,3) 4 (1,9) 6 (2,2)
IIIB 14 (23) 56 (26,5) 70 (25,7)
IIIC 4 (6,6) 11 (5,2) 15 (5,5)
IVA 6 (9,8) 19 (9) 25 (9,2)
IVB 1 (1,6) 0 1 (0,4)
Gradus
I 25 (41) 77 (36,5) 102 (37,5)
0,17†II 24 (39,3) 108 (51,2) 132 (48,5)
III 12 (19,7) 26 (12,3) 38 (14)
Total 61 (100) 211 (100) 272 (100)
*fisher’s exact test; †χ2 test
Table 6.
PATIENTS ACCORDING TO THE ADJUVANT THERAPY  
AND COLON CANCER LOCALIZATION
Number (%) of patients according to 







Yes 44 (72,1) 145 (68,7) 189 (69,5)
0,64
No 17 (27,9) 66 (31,3) 83 (30,5)
Type of adjuvant therapy
Chemotherapy 44 (100) 108 (74,5) 152 (80,4)
0,001Radiotherapy 0 2 (1,4) 2 (1,1)
Chemo- 
radiotherapy 0 35 (24,1) 35 (18,5)
Total 44 (100) 145 (100) 189 (100)
*fisher’s exact test
Table 7.
TIME (MONTHS) UNTIL THE APPEARANCE OF METASTASES 
ACCORDING TO TUMOR COLON LOCALIZATION
Median (interquartil range) according 










8 (4 – 23) 20 (12 – 37) 20 (8 – 29) 0,007
*Mann –Whitney U test
the time median until the occurrence of me-
tastases is 20 months (interquartile range from 8 to 
29 months). The time median is significantly 
shorter in the right colon cancer group of patients. 
(Mann – Whitney U test, p = 0, 007) (table 7).
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recurrences or metastases had 88 (32,4 %) 
patients, 22 (34,9 %) operated patients and 45 
(72,6 %) received chemotherapy (table 8.). 
Statistical analysis
We used Medcalc statistical software version 
18.2.1 (MedCalc Software, Ostend, Belgium; http://
www.medcalc.org; 2018) for statistical analysis.
DISCUSSION
this study included 272 patients treated at 
the institute for oncology of the clinical Medical 
centre in osijek in three years. of the total num-
ber of patients, 42% were women. left colon can-
cer was three times more prevalent than the right 
colon cancer, which is similar to available registry 
data (HZJZ). There was no difference in localiza-
tion when considering patient’s gender.
right sided colon cancer was diagnosed in 
older patients and was larger at diagnosis com-
pared to left sided colon in this cohort. Mika’s 
study showed that right colon cancer is larger in 
diameter and that patients who have it are older. 
That difference in age and size seems related with 
the difference in clinical manifestations, where 
right colon cancer is clinically more silent and 
harder to diagnose than the left colon cancer(31).
on the other hand right sided colon had more 
lymph nodes harvested during surgery, but with-
out significant difference in tumour involved 
lymph nodes when compared to leftside colon 
cancer. However, the involvement of lymph nodes 
in n1 stage is in favour of the left colon cancer, 
while in the n2 stage is in favour of the right colon 
cancer. the lymphovascular invasion did not 
Table 9.
PATIENTS REGARDING THE TREATMENT OUTCOME  
AND CANCER LOCALIZATION
Number (%) of patients according to 







Survived 42 (68,9) 163 (77,3) 205 (75,4)
0,18
Died 19 (31,1) 48 (22,7) 67 (24,6)
Total 61 (100) 211 (100) 272 (100)
*fisher’s exact test
Table 8.
THE APPEARANCE OF METASTASES ACCORDING TO 
TUMOR COLON LOCALIZATION
Number (%) of patients according to 







Yes 21 (34,4) 67 (31,8) 88 (32,4)
0,76
No 40 (65,6) 144 (68,2) 184 (67,6)
Total 61 (100) 211 (100) 272 (100)
Surgical treatment of metastases
Yes 4 (33,3) 18 (35,3) 22 (34,9)
> 0,99
Ne 8 (66,7) 33 (64,7) 41 (65,1)
Total 12 (100) 51 (100) 63 (100)
Chemotherapy of metastases
Yes 9 (81,8) 36 (70,6) 45 (72,6)
0,71
No 2 (18,2) 15 (29,4) 17 (27,4)
Total 11 (100) 51 (100) 62 (100)
*fisher’s exact test
a positive outcome was observed in 205 
(75,4 %) patients, without any significant differ-
ence according to the colon cancer localization 
(table 9)
cancer localization does not show a statisti-
cally significant influence on the overall survival 
rate (Mantel-coxox, p = 0,10). Kaplan–Meier sur-
vival analysis of the patients divided according to 
localization shows an overall five-year survival rate 
of 62% in patients with right colon cancer com-
pared to 72% in patients with left colon cancer.
Figure 1. Kaplan-Meier graph – influence of the cancer localiza-
tionon the total survival rate
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show any significant difference according to the 
localization of the tumor itself. Moreover, when 
comparing stages according to TNM classification 
of tumors, again no difference was found.
as opposed to these results, many studies 
prove that the right colorectal cancer is more often 
in an advanced stage, whereas the left colorectal 
cancer is diagnosed in earlier stages (3,4,8,9,12).
Also, there is a difference in cancer differen-
tiation (gradus). the right colorectal cancer shows 
a poorer differentiation in comparison to the left 
colon cancer, 19,7 % to 12,3 %. this result corre-
sponds to the Dae ro lima’s study conducted in 
south Korea in which more patients (13,5%) with 
right colon cancer show a poor differentiation 
compared to patients (4,3%) with the left colon 
cancer. The difference could arise from the differ-
ent embryonal basis of the left and right colon de-
velopment (31).
time median to recurrences or metastases 
was 20 months. We observed a significant differ-
ence regarding the left and right colon cancer: the 
right colon tumors have a shorter time to recur-
rences or metastases development which is simi-
lar to literature data (3,4,8,9,12,19-2 -26, 29,31,32).
a positive treatment outcome in the survey 
had 205 patients, which makes 75%, with no sig-
nificant difference according to the colorectal can-
cer localization. cancer localization does not show 
a statistically significant influence on the overall 
survival rate (Mantel – cox, p= 0,10).
However, Kaplan – Meier survival analysis 
of the patients divided according to localization, 
shows a overall five year survival rate in 62% of 
patients with right colon cancer in comparison to 
72% in patients with left colon cancer.
glebov’s study shows that a microsatellite in-
stability is more often in the right colorectal can-
cer, while a chromosomal instability is charachter-
istical for left colorectal cancer. Moreover, glebov 
and his associates discovered that over 1000 genes 
have a different expression in right and left 
colorectal cancer (5). the biology of left and right 
colon cancer is rather complex, but gradually re-
veals different surgical and treatment options ac-
cording to its analysis (12-18,25,26,31,32).
CONCLUSIONS
1.  There is a difference in colorectal cancer 
behaviour according to the localization it-
self noticeable in this study.
2.  There is a difference in time to metastases 
or recurrences regarding the localization: 
this period is much shorter for the right 
colon cancer than for the left colon cancer.
3.  There is a difference in the total five year 
survival rate according to the cancer local-
ization, and this total five year survival 
rate is 72% in patients with left colon can-
cer in comparison to 62% in patients with 
right colon cancer.
4.  There is no statistically significant differ-
ence in the cancer localization according 
to the gender.
5.  There is no statistically significant differ-
ence accoring to the tnM staging.
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